PTP’s Health Physics Courses - the best in hands-on radiation safety training

   > By Subject  >Nuclear Medicine show list of document types

 

Number

 

Title

NRC

Guide

Licensing Guide for Diagnostic Nuclear Medicine

NRC

RegGuide 8.39

Release of Patients Administered Radioactive Materials (Draft DG-8015 published 6/1994) (Errata published 5/1997)

NRC

RegGuide 10.8

Guide for the Preparation of Applications for Medical Use Programs (Draft FC 415-4, Proposed Revision 2, published 8/1985) (Draft DG-0002, Proposed Appendix X to Regulatory Guide 10.8, published 12/1991) (Appendix X published June 1992) (DG-0009, Proposed Supplement, published 3/1997)

NRC

NUREG 1516

Management of Radioactive Material Safety Programs at Medical Facilities

NRC

NUREG 1556

Consolidated Guidance About Materials Licenses: Vol. 9: "Program-Specific Guidance About Medical Use Licenses (Rev. 1. May 2005)

NRC

RIS 08-011

Precautions To Protect Children Who May Come In Contact With Patients Released After Therapeutic Administration Of Iodine-131

NRC

RIS 02-020

NRC Regulatory Issue Summary 2002-20: Clarification of Requirements Under 10 CFR 35.432,"Calibration Measurements of Brachytherapy Sources"

NRC

RIS 02-019

New Modalities to be Regulated under 10 CFR 35.1000 - NRC Regulatory Issue Summary 2002-19

NRC

RIS 02-006

Evaluating Occupational Dose for Individuals Exposed to NRC-licensed Material and Medical X-rays -NRC Regulatory Issue Summary 2002-06:

NRC

HPPOS145

Authorized Users' Supervision of Medical Programs

NRC

HPPOS262

Radioactive Drug Research Committees

NRC

HPPOS270

Interpretation of 10 CFR 35.33(c) Regarding Diagnostic Misadministration Reporting Threshold Levels

NRC

HPPOS286

Angell Memorial Animal Hospital, Boston, MA; Release to Unrestricted Area of Animals Containing Iodine-131

NRC

HPPOS313

Whether a Cardiologist Must be Authorized by NRC to Interpret Nuclear Medicine Patient Scans, DePaul Hospital, Cheyenne, WY

NRC

HPPOS319

Policy Guidance Concerning Use of Xenon-133 in Saline

NRC

HPPOS320

Regarding Mediq Imaging, Inc., Providing Service to a Private Practice (Non-licensee) Located within a Hospital

NRC

HPPOS321

Guidance on Setting Action Levels for Exemption for Requirement to Decontaminate Therapy Room for Unrestricted Use

NRC

In02028

Problems Involved in Monitoring Dose to the Hands Resulting from the Handling of Radiopharmaceuticals In03012

NRC

In02028

Appointment of Radiation Safety Officers and Authorized Users Under 10 CFR Part 35

NRC

In02023

Unauthorized Administration of Byproduct Material For Medical Use

NRC

In02019

Medical Misadministrations Caused by Failure to Properly Perform Tests on Dose Calibrators for Beta-and-Low Energy Photon-Emitting Radionuclides In02019

NRC

In02017

Medical use of Strontium-90 Eye Applicators: New Requirements for Calibration and Decay Correction In02017

NRC

In02016

Intravascular Brachytherapy Misadministrations In02016

NRC

In00005

Recent Medical Misadministrations Resulting from Inattention to Detail

NRC

In94007

Radiopharmaceutical Vial Breakage During Preparation

NRC

In94070

Issues Associated with Use of Strontium-90 and Other Beta Emitting Radiopharmaceuticals

NRC

In93010

Dose Calibrator Quality Control

NRC

In90059

Errors in the Use of Radioactive Iodine-131

NRC

In90071

Effective Use of Radiation Safety Committees to Exercise Control Over Medical Use Program

NRC

In89012

Dose Calibrator Quality Control

NRC

In89074

Clarification of Transportation Requirements Applicable to Return of Spent Radiopharmacy Dosages From Users to Suppliers

NRC

In84085

Molybdenum Breakthrough From Technetium-99m Generators

ORAU

NUREG 6345

A Compendium Of Dose Estimates For Many Radiopharmaceuticals

ORAU

 

Radiation Dose Estimates To Adults And Children From Various Radiopharmaceuticals

ORAU

 

Tables Of Radiation Absorbed Dose To The Embryo/Fetus From Radiopharmaceuticals. See Health Physics (73[5]:756-769, 1997).

ORAU

 

Guidelines For Breastfeeding Mothers In Nuclear Medicine

ORAU

 

Health Concerns Related to Radiation Exposure of the Female Nuclear Medicine Patient

ORAU

 

Comparison of Effective Dose Equivalent (ICRP 30), Effective Dose (ICRP 60), and Total Body Dose for 62 Radiopharmaceutical Procedures

 

NL-SA-18458

Contributions And Future Of Radioisotopes In Medical, Industrial, And Space Applications